Next Article in Journal
Previous Article in Journal
Previous Article in Special Issue
Pharmaceutics 2012, 4(2), 252-275; doi:10.3390/pharmaceutics4020252
Other

Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems

1
, 1
, 1,2
 and 3,*
Received: 8 February 2012; in revised form: 17 April 2012 / Accepted: 5 May 2012 / Published: 14 May 2012
(This article belongs to the Special Issue Ocular Drug Delivery)
View Full-Text   |   Download PDF [687 KB, updated 16 May 2012; original version uploaded 14 May 2012]   |   Browse Figures
Abstract: Several drug delivery systems have been proposed to overcome physiological barriers, improving ocular bioavailability. Systemic routes are seldom used due to the blood-ocular barrier. Novel drug delivery systems based on nanotechnology techniques have been developed to overcome ocular physiological barriers. This non-systematic review suggests the utilization of a transitory blood-ocular breakdown to allow the access of drugs by nanotechnology drug delivery systems via the systemic route. We discuss the possible ways to cause the breakdown of the blood-ocular barrier: acute inflammation caused by intraocular surgery, induced ocular hypotony, and the use of inflammatory mediators. The suitability of use of the systemic route and its toxic effects are also discussed in this article.
Keywords: blood-ocular barrier; hypotony; nanotechnology; ocular drug delivery system; ocular inflammatory mediators; systemic route blood-ocular barrier; hypotony; nanotechnology; ocular drug delivery system; ocular inflammatory mediators; systemic route
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Occhiutto, M.L.; Freitas, F.R.; Maranhao, R.C.; Costa, V.P. Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems. Pharmaceutics 2012, 4, 252-275.

AMA Style

Occhiutto ML, Freitas FR, Maranhao RC, Costa VP. Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems. Pharmaceutics. 2012; 4(2):252-275.

Chicago/Turabian Style

Occhiutto, Marcelo L.; Freitas, Fatima R.; Maranhao, Raul C.; Costa, Vital P. 2012. "Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems." Pharmaceutics 4, no. 2: 252-275.



Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert